Skip to main content
Fig. 7 | Alzheimer's Research & Therapy

Fig. 7

From: Five-mer peptides prevent short-term spatial memory deficits in Aβ25-35-induced Alzheimer’s model mouse by suppressing Aβ25-35 aggregation and resolving its aggregate form

Fig. 7

Prevention of short-term spatial-memory impairment by GSGFK. Y-maze test was performed at 11, 27, and 39 days after intracerebroventricular injection of saline, 9 nmol Aβ25-35, or a reaction mixture of 9 nmol Aβ25-35 and 9 nmol GSGFK. Data shown are mean ± standard error of the mean (n = 5). *p < 0.05. Saline: p = 0.021 (Day 11), p =  < 0.001 (Day 27), p = 0.001 (Day 39); GSGFK: p =  < 0.001 (Day 27), p = 0.001 (Day 39)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193